M24 logotipas

M24.lt

VaistaiMPPKompensavimasTLKAsistentas
PrisijungtiRegistruotis

/

ATC kodai

/

L01F: Monoclonal antibodies and antibody drug conjugates

ATC kodas

L01F: Monoclonal antibodies and antibody drug conjugates

L: Antinavikiniai vaistai ir imunomoduliatoriai»L01: Tisagenlekleucelas»L01F: Monoclonal antibodies and antibody drug conjugates

Vaistiniai preparatai

126

Kompensuojami

33

Tiekimo sutrikimai

6

Pogrupiai

L01FA: Cd20 (clusters of differentiation 20) inhibitorsL01FB: Cd22 (clusters of differentiation 22) inhibitorsL01FC: Cd38 (clusters of differentiation 38) inhibitorsL01FD: Her2 (human epidermal growth factor receptor 2) inhibitorsL01FE: Egfr (epidermal growth factor receptor) inhibitorsL01FF: Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitorsL01FG: Vegf/vegfr (vascular endothelial growth factor) inhibitorsL01FX: Other monoclonal antibodies and antibody drug conjugates

Vaistiniai preparatai

Forma

Stiprumas

Veiklioji medžiaga

Gamintojas

Kompensuojami

Rūšiuoti pagal:

Lunsumio

injekcinis tirpalas

5 mg

Mosunetuzumabas

Roche Registration GmbH

-

R
S
-
Lunsumio, injekcinis tirpalas, 5 mg

Mosunetuzumabas, 5 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
Lunsumio

injekcinis tirpalas

45 mg

Mosunetuzumabas

Roche Registration GmbH

-

R
S
-
Lunsumio, injekcinis tirpalas, 45 mg

Mosunetuzumabas, 45 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
Lunsumio

koncentratas infuziniam tirpalui

1 mg

Mosunetuzumabas

Roche Registration GmbH

-

R
S
-
Lunsumio, koncentratas infuziniam tirpalui, 1 mg

Mosunetuzumabas, 1 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
LYNOZYFIC

koncentratas infuziniam tirpalui

5 mg

Linvoseltamabas

Regeneron Ireland Designated Activity Co...

-

R
S
-
LYNOZYFIC, koncentratas infuziniam tirpalui, 5 mg

Linvoseltamabas, 5 mg

Regeneron Ireland Designated Activity Co...
Netiekiama
Receptinis
-
LYNOZYFIC

koncentratas infuziniam tirpalui

200 mg

Linvoseltamabas

Regeneron Ireland Designated Activity Co...

-

R
S
-
LYNOZYFIC, koncentratas infuziniam tirpalui, 200 mg

Linvoseltamabas, 200 mg

Regeneron Ireland Designated Activity Co...
Netiekiama
Receptinis
-
MabThera

koncentratas infuziniam tirpalui

500 mg

Rituksimabas

Roche Registration GmbH

-

R
S
-
MabThera, koncentratas infuziniam tirpalui, 500 mg

Rituksimabas, 500 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
MabThera

koncentratas infuziniam tirpalui

100 mg

Rituksimabas

Roche Registration GmbH

-

R
S
-
MabThera, koncentratas infuziniam tirpalui, 100 mg

Rituksimabas, 100 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
MabThera

injekcinis tirpalas

1400 mg

Rituksimabas

Roche Registration GmbH

-

R
S
-
MabThera, injekcinis tirpalas, 1400 mg

Rituksimabas, 1400 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
MabThera

injekcinis tirpalas

1600 mg

Rituksimabas

Roche Registration GmbH

-

R
S
-
MabThera, injekcinis tirpalas, 1600 mg

Rituksimabas, 1600 mg

Roche Registration GmbH
Netiekiama
Receptinis
-
MINJUVI

milteliai infuzinio tirpalo koncentratui

200 mg

Tafasitamabas

Incyte Biosciences Distribution B.V.

-

R
S
-
MINJUVI, milteliai infuzinio tirpalo koncentratui, 200 mg

Tafasitamabas, 200 mg

Incyte Biosciences Distribution B.V.
Netiekiama
Receptinis
-
MVASI

koncentratas infuziniam tirpalui

25 mg/ml

Bevacizumabas

Amgen Technology (Ireland) UC

-

R
S
-
MVASI, koncentratas infuziniam tirpalui, 25 mg/ml

Bevacizumabas, 25 mg/ml

Amgen Technology (Ireland) UC
Netiekiama
Receptinis
-
Ogivri

milteliai infuzinio tirpalo koncentratui

420 mg

Trastuzumabas

Biosimilar Collaborations Ireland Limite...

-

R
S
-
Ogivri, milteliai infuzinio tirpalo koncentratui, 420 mg

Trastuzumabas, 420 mg

Biosimilar Collaborations Ireland Limite...
Netiekiama
Receptinis
-
Ontruzant

milteliai infuzinio tirpalo koncentratui

420 mg

Trastuzumabas

Samsung Bioepis NL B.V.

-

R
S
-
Ontruzant, milteliai infuzinio tirpalo koncentratui, 420 mg

Trastuzumabas, 420 mg

Samsung Bioepis NL B.V.
Netiekiama
Receptinis
-
OPDIVO

injekcinis tirpalas

600 mg

Nivolumabas

Bristol-Myers Squibb/Pfizer EEIG

-

R
S
-
OPDIVO, injekcinis tirpalas, 600 mg

Nivolumabas, 600 mg

Bristol-Myers Squibb/Pfizer EEIG
Netiekiama
Receptinis
-
Opdualag

koncentratas infuziniam tirpalui

240 mg/80 mg

Nivolumabas / Relatlimabas

Bristol-Myers Squibb Pharma EEIG

-

R
S
-
Opdualag, koncentratas infuziniam tirpalui, 240 mg/80 mg

Nivolumabas / Relatlimabas, 240 mg/80 mg

Bristol-Myers Squibb Pharma EEIG
Netiekiama
Receptinis
-
Ordspono

koncentratas infuziniam tirpalui

2 mg

Odronekstamabas

Regeneron Ireland Designated Activity Co...

-

R
S
-
Ordspono, koncentratas infuziniam tirpalui, 2 mg

Odronekstamabas, 2 mg

Regeneron Ireland Designated Activity Co...
Netiekiama
Receptinis
-
Ordspono

koncentratas infuziniam tirpalui

320 mg

Odronekstamabas

Regeneron Ireland Designated Activity Co...

-

R
S
-
Ordspono, koncentratas infuziniam tirpalui, 320 mg

Odronekstamabas, 320 mg

Regeneron Ireland Designated Activity Co...
Netiekiama
Receptinis
-
Ordspono

koncentratas infuziniam tirpalui

80 mg

Odronekstamabas

Regeneron Ireland Designated Activity Co...

-

R
S
-
Ordspono, koncentratas infuziniam tirpalui, 80 mg

Odronekstamabas, 80 mg

Regeneron Ireland Designated Activity Co...
Netiekiama
Receptinis
-
Padcev

milteliai infuzinio tirpalo koncentratui

30 mg

Enfortumabas vedotinas

Astellas Pharma Europe B.V.

-

R
S
-
Padcev, milteliai infuzinio tirpalo koncentratui, 30 mg

Enfortumabas vedotinas, 30 mg

Astellas Pharma Europe B.V.
Netiekiama
Receptinis
-
Padcev

milteliai infuzinio tirpalo koncentratui

20 mg

Enfortumabas vedotinas

Astellas Pharma Europe B.V.

-

R
S
-
Padcev, milteliai infuzinio tirpalo koncentratui, 20 mg

Enfortumabas vedotinas, 20 mg

Astellas Pharma Europe B.V.
Netiekiama
Receptinis
-
«1

…

4567»